Refocus Group, Inc. is a medical device company engaged in the research and development of treatments for human vision disorders. Our mission is to become the surgical standard of care for presbyopia. Refocus Group's latest product is the VisAbility™ Implant System, which is used in an innovative procedure known as the VisAbility™ Procedure. The implant is an investigational device and is not yet approved for sale or use in the United States or Canada. However, the product is currently approved for sale in the European Union.